Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study-Reference-Cited by-同舟云学术

Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study

Published:2008-01-17 Issue:4 Volume:22 Page:842-849
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

San-Miguel J F,Richardson P G,Sonneveld P,Schuster M W,Irwin D,Stadtmauer E A,Facon T,Harousseau J-L,Ben-Yehuda D,Lonial S,Goldschmidt H,Reece D,Bladé J,Boccadoro M,Cavenagh J D,Neuwirth R,Boral A L,Esseltine D-L,Anderson K C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2405087.pdf

Reference32 articles.

1. Penfield JG . Multiple myeloma in end-stage renal disease. Semin Dial 2006; 19: 329–334.

2. Knudsen LM, Hippe E, Hjorth M, Holmberg E, Westin J . Renal function in newly diagnosed multiple myeloma—a demographic study of 1353 patients. The nordic myeloma study group. Eur J Haematol 1994; 53: 207–212.

3. Knudsen LM, Hjorth M, Hippe E . Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic myeloma study group. Eur J Haematol 2000; 65: 175–181.

4. Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom medical research council trials between 1980 and 2002—medical research council adult leukaemia working party. J Clin Oncol 2005; 23: 9219–9226.

5. Alexanian R, Barlogie B, Dixon D . Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 1990; 150: 1693–1695.

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial;Nature Communications;2024-08-27

2. Clinical and economic burden of medicare beneficiaries with multiple myeloma and renal impairment: An observational study;Medicine;2024-06-28

3. Treatment outcomes of multiple myeloma in patients requiring renal replacement therapy;Journal of Renal Injury Prevention;2024-04-04

4. Risk nomogram for assessing renal recovery in patients with newly diagnosed multiple myeloma-related renal impairment;Current Problems in Cancer;2023-08

5. Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation;International Journal of Hematology;2023-07-07